NDC 0407-0747-02 - Hypaque Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0407-0747
- Requested NDC
- 0407-0747-02
- Package NDCs from labels
- 0407-0747-02
- Manufacturer
- Amersham Health Inc.
- Effective date
- 2007-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYPAQUE ™ Meglumine (Diatrizoate Meglumine Injection, USP) 60% | Amersham Health Inc. | 2007-08-03 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0407-0747-02 | Hypaque Sodium | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 1 | |
| 0407-0747-02 | Hypaque Sodium | 100 mL in 1 VIAL | INJECTION, SOLUTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Diatrizoate Meglumine | ACTIVE INGREDIENT | 3X9MR4N98U | HYPAQUE SODIUM (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 | |
| diatrizoic acid | ACTIVE MOIETY | 5UVC90J1LK | HYPAQUE SODIUM (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 23DF6AB0-CDBC-9415-26B6-CB075042D30E | A0B58C0C-D67A-4BA6-8D84-CCDC78F24634 | 2007-08-03 | Warnings, Adverse reactions | 23DF6AB0-CDBC-9415-26B6-CB075042D30E A0B58C0C-D67A-4BA6-8D84-CCDC78F24634 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.